Immunitas Therapeutics (United States)
- Research works
- 5 ▲ 900% vs 2018-21
- Citations
- 51 11.3 per fractional work
- Top-10% rate
- 9.9% all institutions 10.0%
- Open access
- 81% world 40%
- International
- 37% world 18%
Not ranked overall: Immunitas Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Immunitas Therapeutics (United States) work in?
In all years, 66% of research at Immunitas Therapeutics (United States) is in Health Sciences, 34% in Life Sciences. Its largest fields are Medicine (66%), Immunology and Microbiology (32%), Biochemistry, Genetics and Molecular Biology (2%). It does 1.5× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 2 domains and 3 fields, with their numbers
- Health Sciences365.9%
- Medicine365.9%
- Life Sciences234.1%
Who are the top researchers at Immunitas Therapeutics (United States)?
Ranked on the quality score, Ming Tang lead among researchers whose main affiliation is Immunitas Therapeutics (United States).
- 1
Ming Tang
United States · #1,350,769 worldwide 334 citations · 70 works
Which research topics does Immunitas Therapeutics (United States) publish most on?
By volume in 2022-now: Immune Cell Function and Interaction, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and Cytokine Signaling Pathways and Interactions.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Immune Cell Function and Interaction Immunology 1 works
- 2 CAR-T cell therapy research Oncology 1 works
- 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 4 Cytokine Signaling Pathways and Interactions Oncology 0 works
- 5 Chronic Kidney Disease and Diabetes Nephrology 0 works
- 6 Renin-Angiotensin System Studies Cardiology and Cardiovascular Medicine 0 works
- 7 Renal Diseases and Glomerulopathies Nephrology 0 works
- 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 9 Biosimilars and Bioanalytical Methods Immunology 0 works
- 10 Immunotherapy and Immune Responses Immunology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Immunitas Therapeutics (United States)'s research output changed?
Output in 2022-2025 was 900% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Waltham
- Brandeis University
- Thermo Fisher Scientific (United States)
- Bentley University
- PerkinElmer (United States)
- Education Development Center
- Foster-Miller (United States)
- Boston Engineering (United States)
- ImmunoGen (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Immunitas Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.